CNS Stock Analysis: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$81.42
0.63 (0.78%)
â˛
5d:
-3.92%
30d:
+1.8%
90d:
+12.85%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 15, 2026
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CNS is fairly priced but lacks strong directional signals. At 2.7% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CNS is fairly priced but lacks strong directional signals. At 2.7% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$111.50
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$69.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $81.42, which is considered slightly low relative to its 30-day fair value range of $80.80 to $84.26. The stock's valuation (Forward PE: 20.5) is in line with its historical norms (18.9). At these levels, the market is pricing in 2.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNS is in a strong uptrend. The price is currently testing key support at $79.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CNS scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNS is in a strong uptrend. The price is currently testing key support at $79.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CNS scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$80.80 -
$84.26
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
51.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($76.00)
- NEUTRAL: Market pricing in 2.7% annual earnings growth - fairly valued
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$80.80 -
$84.26
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$79.89
Resistance Level
$86.56
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.47
Wall Street Target
$76.00
(-6.7%)
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
31.9%
Profit Margin
28.8%
Valuation Premium vs History
+2.7% premium
PE vs Historical
20.5 vs 18.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.7%
(market-implied from PE analysis)
1-Year Target
$83.62
(+3%)
2-Year Target
$85.88
(+6%)
3-Year Target
$88.19
(+8%)
3-Yr Target (if PE normalizes)
(PE: 20â19)
PE COMPRESSION
$81.41
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.5, Growth: 12.5%)
$116.08
(+43%)
Base:
(SPY PE: 20.1, Growth: 12.5%)
$113.79
(+40%)
Bear:
(PE: 17.1, Growth: 12.5%)
$96.72
(+19%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 25.01 | Current EPS (TTM): $3.23
Bull Case
$109.41
(+34%)
Analyst growth 23.1%, PE expands to 27.5
Base Case
$99.47
(+22%)
Market implied 23.1%, PE stable at 25.0
Bear Case
$54.94
(-33%)
Severe decline -20.0%, PE contracts to 21.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 3:45 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
Data refreshes hourly during market hours. Next update: 4:45 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1314 | 44 HOLD |
|
HASI
Hannon Armstrong SustainâĻ |
STRONG BUY
16 analysts |
$50 | 51 HOLD |
|
APO
Apollo Global ManagementâĻ |
STRONG BUY
19 analysts |
$153 | 42 HOLD |
|
ARCC
Ares Capital Corporation |
STRONG BUY
13 analysts |
$21 | 51 HOLD |
|
BN
Brookfield Corp |
STRONG BUY
11 analysts |
$55 | 51 HOLD |
